Financials
- Market Capitalization 395.23 M
- Employee 120
- Founded 1995
- CEO N/A
- Website www.enanta.com
- Headquarter Massachusetts, United States
- FIGI BBG001V9NSB4
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3.12
Relación precio/flujo de caja
0
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3075 | XFOR X4 Pharmaceuticals, Inc. - Common Stock | 4.06 USD | -4.02% | 0.00% | +3.31% | +36.70% | 402.54 M USD | ||
| 3076 | CTNM Contineum Therapeutics, Inc. - Common stock | 17.39 USD | +0.81% | +1.28% | +22.72% | +13.88% | 401.69 M USD | ||
| 3092 | LXEO Lexeo Therapeutics, Inc. - Common Stock | 4.80 USD | -3.81% | -2.24% | +9.34% | -0.21% | 393.82 M USD | ||
| 3109 | EYPT EyePoint, Inc. - Common Stock | 4.47 USD | -3.46% | -12.52% | -62.69% | -62.75% | 385.37 M USD |